APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Modafinil Oral Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Modafinil Oral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174013910327 December 2025187 pages

Choose your research edition.

Industry ResearchModafinil Oral Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Modafinil Oral Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Modafinil Oral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Modafinil Oral Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Modafinil Oral Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Modafinil Oral Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Modafinil Oral Drugs include Xiangbei Welman Pharmaceutical, Zydus, Watson Labs, Sun Pharmaceutical, Orbion Pharmaceuticals, Cephalon, Aurobindo Pharma, Apotex and Alembic Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Modafinil Oral Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Modafinil Oral Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Modafinil Oral Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Modafinil Oral Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Modafinil Oral Drugs Segment by Company

Xiangbei Welman Pharmaceutical

Zydus

Watson Labs

Sun Pharmaceutical

Orbion Pharmaceuticals

Cephalon

Aurobindo Pharma

Apotex

Alembic Pharma

Modafinil Oral Drugs Segment by Type

Tablets

Capsules

Modafinil Oral Drugs Segment by Application

Obstructive Sleep Apnea

Shift Work Sleep Disorder

Narcolepsy

Other

Modafinil Oral Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modafinil Oral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modafinil Oral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modafinil Oral Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Modafinil Oral Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Modafinil Oral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Modafinil Oral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Modafinil Oral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Modafinil Oral Drugs Industry Trends Table 2. Modafinil Oral Drugs Industry Drivers Table 3. Modafinil Oral Drugs Industry Opportunities and Challenges Table 4. Modafinil Oral Drugs Industry Restraints Table 5. Global Modafinil Oral Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Modafinil Oral Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Modafinil Oral Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Modafinil Oral Drugs Sales Market Share by Manufacturers Table 9. Global Modafinil Oral Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Modafinil Oral Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Modafinil Oral Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Modafinil Oral Drugs Manufacturers, Product Type & Application Table 13. Global Modafinil Oral Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Modafinil Oral Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Capsules Table 18. Global Modafinil Oral Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Modafinil Oral Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Modafinil Oral Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Modafinil Oral Drugs Sales Market Share by Type (2021-2026) Table 22. Global Modafinil Oral Drugs Sales Market Share by Type (2027-2032) Table 23. Global Modafinil Oral Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Modafinil Oral Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Modafinil Oral Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Modafinil Oral Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Modafinil Oral Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Obstructive Sleep Apnea Table 29. Major Manufacturers of Shift Work Sleep Disorder Table 30. Major Manufacturers of Narcolepsy Table 31. Major Manufacturers of Other Table 32. Global Modafinil Oral Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Modafinil Oral Drugs Sales by Application (2021-2026) & (K Units) Table 34. Global Modafinil Oral Drugs Sales by Application (2027-2032) & (K Units) Table 35. Global Modafinil Oral Drugs Sales Market Share by Application (2021-2026) Table 36. Global Modafinil Oral Drugs Sales Market Share by Application (2027-2032) Table 37. Global Modafinil Oral Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Modafinil Oral Drugs Revenue by Application (2021-2026) & (K Units) Table 39. Global Modafinil Oral Drugs Revenue by Application (2027-2032) & (K Units) Table 40. Global Modafinil Oral Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Modafinil Oral Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Modafinil Oral Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Modafinil Oral Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Modafinil Oral Drugs Sales Market Share by Region (2021-2026) Table 45. Global Modafinil Oral Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Modafinil Oral Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 49. North America Modafinil Oral Drugs Sales by Country (2027-2032) & (K Units) Table 50. Europe Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 52. Europe Modafinil Oral Drugs Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Modafinil Oral Drugs Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Modafinil Oral Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Modafinil Oral Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Modafinil Oral Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Modafinil Oral Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Modafinil Oral Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Modafinil Oral Drugs Revenue Market Share by Region (2027-2032) Table 64. Xiangbei Welman Pharmaceutical Company Information Table 65. Xiangbei Welman Pharmaceutical Business Overview Table 66. Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio Table 68. Xiangbei Welman Pharmaceutical Recent Development Table 69. Zydus Company Information Table 70. Zydus Business Overview Table 71. Zydus Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zydus Modafinil Oral Drugs Product Portfolio Table 73. Zydus Recent Development Table 74. Watson Labs Company Information Table 75. Watson Labs Business Overview Table 76. Watson Labs Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Watson Labs Modafinil Oral Drugs Product Portfolio Table 78. Watson Labs Recent Development Table 79. Sun Pharmaceutical Company Information Table 80. Sun Pharmaceutical Business Overview Table 81. Sun Pharmaceutical Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio Table 83. Sun Pharmaceutical Recent Development Table 84. Orbion Pharmaceuticals Company Information Table 85. Orbion Pharmaceuticals Business Overview Table 86. Orbion Pharmaceuticals Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio Table 88. Orbion Pharmaceuticals Recent Development Table 89. Cephalon Company Information Table 90. Cephalon Business Overview Table 91. Cephalon Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Cephalon Modafinil Oral Drugs Product Portfolio Table 93. Cephalon Recent Development Table 94. Aurobindo Pharma Company Information Table 95. Aurobindo Pharma Business Overview Table 96. Aurobindo Pharma Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Aurobindo Pharma Modafinil Oral Drugs Product Portfolio Table 98. Aurobindo Pharma Recent Development Table 99. Apotex Company Information Table 100. Apotex Business Overview Table 101. Apotex Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Apotex Modafinil Oral Drugs Product Portfolio Table 103. Apotex Recent Development Table 104. Alembic Pharma Company Information Table 105. Alembic Pharma Business Overview Table 106. Alembic Pharma Modafinil Oral Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Alembic Pharma Modafinil Oral Drugs Product Portfolio Table 108. Alembic Pharma Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Modafinil Oral Drugs Distributors List Table 112. Modafinil Oral Drugs Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Modafinil Oral Drugs Product Image Figure 2. Global Modafinil Oral Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Modafinil Oral Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Modafinil Oral Drugs Sales (2021-2032) & (K Units) Figure 5. Global Modafinil Oral Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Modafinil Oral Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Capsules Image Figure 10. Global Modafinil Oral Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Modafinil Oral Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Modafinil Oral Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Modafinil Oral Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Modafinil Oral Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Modafinil Oral Drugs Revenue Market Share by Type (2021-2032) Figure 16. Obstructive Sleep Apnea Image Figure 17. Shift Work Sleep Disorder Image Figure 18. Narcolepsy Image Figure 19. Other Image Figure 20. Global Modafinil Oral Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Modafinil Oral Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Modafinil Oral Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Modafinil Oral Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Modafinil Oral Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Modafinil Oral Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Modafinil Oral Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Modafinil Oral Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Modafinil Oral Drugs Sales Market Share by Country (2021-2032) Figure 40. China Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Modafinil Oral Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Modafinil Oral Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Modafinil Oral Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Modafinil Oral Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Modafinil Oral Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Modafinil Oral Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Modafinil Oral Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Modafinil Oral Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Modafinil Oral Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Modafinil Oral Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Obstructive Sleep Apnea
  • Shift Work Sleep Disorder
  • Narcolepsy
  • Other
Companies covered
  • Xiangbei Welman Pharmaceutical
  • Zydus
  • Watson Labs
  • Sun Pharmaceutical
  • Orbion Pharmaceuticals
  • Cephalon
  • Aurobindo Pharma
  • Apotex
  • Alembic Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Modafinil Oral Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Modafinil Oral Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Modafinil Oral Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Modafinil Oral Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Modafinil Oral Drugs Market Dynamics
  1. 2.1 Modafinil Oral Drugs Industry Trends
  2. 2.2 Modafinil Oral Drugs Industry Drivers
  3. 2.3 Modafinil Oral Drugs Industry Opportunities and Challenges
  4. 2.4 Modafinil Oral Drugs Industry Restraints
3 Modafinil Oral Drugs Market by Manufacturers
  1. 3.1 Global Modafinil Oral Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Modafinil Oral Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Modafinil Oral Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Modafinil Oral Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Modafinil Oral Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Modafinil Oral Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Modafinil Oral Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Modafinil Oral Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Modafinil Oral Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Modafinil Oral Drugs Tier 1, Tier 2, and Tier 3
4 Modafinil Oral Drugs Market by Type
  1. 4.1 Modafinil Oral Drugs Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Modafinil Oral Drugs Sales by Type
  5. 4.2.1 Global Modafinil Oral Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Modafinil Oral Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Modafinil Oral Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Modafinil Oral Drugs Revenue by Type
  9. 4.3.1 Global Modafinil Oral Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Modafinil Oral Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Modafinil Oral Drugs Revenue Market Share by Type (2021-2032)
5 Modafinil Oral Drugs Market by Application
  1. 5.1 Modafinil Oral Drugs Application Introduction
  2. 5.1.1 Obstructive Sleep Apnea
  3. 5.1.2 Shift Work Sleep Disorder
  4. 5.1.3 Narcolepsy
  5. 5.1.4 Other
  6. 5.2 Global Modafinil Oral Drugs Sales by Application
  7. 5.2.1 Global Modafinil Oral Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Modafinil Oral Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Modafinil Oral Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Modafinil Oral Drugs Revenue by Application
  11. 5.3.1 Global Modafinil Oral Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Modafinil Oral Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Modafinil Oral Drugs Revenue Market Share by Application (2021-2032)
6 Global Modafinil Oral Drugs Sales by Region
  1. 6.1 Global Modafinil Oral Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Modafinil Oral Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Modafinil Oral Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Modafinil Oral Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Modafinil Oral Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Modafinil Oral Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Modafinil Oral Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Modafinil Oral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Modafinil Oral Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Modafinil Oral Drugs Revenue by Region
  1. 7.1 Global Modafinil Oral Drugs Revenue by Region
  2. 7.1.1 Global Modafinil Oral Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Modafinil Oral Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Modafinil Oral Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Modafinil Oral Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Modafinil Oral Drugs Revenue (2021-2032)
  8. 7.2.2 North America Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Modafinil Oral Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Modafinil Oral Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Modafinil Oral Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Modafinil Oral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Xiangbei Welman Pharmaceutical
  2. 8.1.1 Xiangbei Welman Pharmaceutical Company Information
  3. 8.1.2 Xiangbei Welman Pharmaceutical Business Overview
  4. 8.1.3 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio
  6. 8.1.5 Xiangbei Welman Pharmaceutical Recent Developments
  7. 8.2 Zydus
  8. 8.2.1 Zydus Company Information
  9. 8.2.2 Zydus Business Overview
  10. 8.2.3 Zydus Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zydus Modafinil Oral Drugs Product Portfolio
  12. 8.2.5 Zydus Recent Developments
  13. 8.3 Watson Labs
  14. 8.3.1 Watson Labs Company Information
  15. 8.3.2 Watson Labs Business Overview
  16. 8.3.3 Watson Labs Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Watson Labs Modafinil Oral Drugs Product Portfolio
  18. 8.3.5 Watson Labs Recent Developments
  19. 8.4 Sun Pharmaceutical
  20. 8.4.1 Sun Pharmaceutical Company Information
  21. 8.4.2 Sun Pharmaceutical Business Overview
  22. 8.4.3 Sun Pharmaceutical Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio
  24. 8.4.5 Sun Pharmaceutical Recent Developments
  25. 8.5 Orbion Pharmaceuticals
  26. 8.5.1 Orbion Pharmaceuticals Company Information
  27. 8.5.2 Orbion Pharmaceuticals Business Overview
  28. 8.5.3 Orbion Pharmaceuticals Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio
  30. 8.5.5 Orbion Pharmaceuticals Recent Developments
  31. 8.6 Cephalon
  32. 8.6.1 Cephalon Company Information
  33. 8.6.2 Cephalon Business Overview
  34. 8.6.3 Cephalon Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cephalon Modafinil Oral Drugs Product Portfolio
  36. 8.6.5 Cephalon Recent Developments
  37. 8.7 Aurobindo Pharma
  38. 8.7.1 Aurobindo Pharma Company Information
  39. 8.7.2 Aurobindo Pharma Business Overview
  40. 8.7.3 Aurobindo Pharma Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aurobindo Pharma Modafinil Oral Drugs Product Portfolio
  42. 8.7.5 Aurobindo Pharma Recent Developments
  43. 8.8 Apotex
  44. 8.8.1 Apotex Company Information
  45. 8.8.2 Apotex Business Overview
  46. 8.8.3 Apotex Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Apotex Modafinil Oral Drugs Product Portfolio
  48. 8.8.5 Apotex Recent Developments
  49. 8.9 Alembic Pharma
  50. 8.9.1 Alembic Pharma Company Information
  51. 8.9.2 Alembic Pharma Business Overview
  52. 8.9.3 Alembic Pharma Modafinil Oral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alembic Pharma Modafinil Oral Drugs Product Portfolio
  54. 8.9.5 Alembic Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Modafinil Oral Drugs Value Chain Analysis
  2. 9.1.1 Modafinil Oral Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Modafinil Oral Drugs Production Mode & Process
  6. 9.2 Modafinil Oral Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Modafinil Oral Drugs Distributors
  9. 9.2.3 Modafinil Oral Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst